We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Submits Final PDUFA Recommendations to Congress
FDA Submits Final PDUFA Recommendations to Congress
March 30, 2007
The FDA has sent Congress its final recommendations for the reauthorization of the Prescription Drug User Fee Act (PDUFA),
including an increase in user fees to pay for drug safety reviews, as well as reviews of direct-to-consumer (DTC) advertising.